|
CPSF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.22770041197396E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.25269996995326E-09 |
| Normal-vs-Stage2 |
1.530240E-02 |
| Normal-vs-Stage3 |
2.216600E-03 |
| Normal-vs-Stage4 |
4.80749999998142E-06 |
| Stage1-vs-Stage2 |
4.375000E-01 |
| Stage1-vs-Stage3 |
2.590800E-01 |
| Stage1-vs-Stage4 |
1.931970E-01 |
| Stage2-vs-Stage3 |
9.034200E-01 |
| Stage2-vs-Stage4 |
1.369210E-01 |
| Stage3-vs-Stage4 |
5.141900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.85709999892481E-09 |
| Normal-vs-AfricanAmerican |
9.67170000000239E-05 |
| Normal-vs-Asian |
3.151900E-02 |
| Caucasian-vs-AfricanAmerican |
4.414800E-01 |
| Caucasian-vs-Asian |
1.036210E-02 |
| AfricanAmerican-vs-Asian |
1.576810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77290000458186E-08 |
| Normal-vs-Female |
3.82410000332456E-08 |
| Male-vs-Female |
9.857000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.394200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.52550000001683E-06 |
| Normal-vs-Age(61-80Yrs) |
1.48150003376202E-09 |
| Normal-vs-Age(81-100Yrs) |
2.983900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.831000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.733000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.807200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.550430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.796200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.119400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.170400E-02 |
| Normal-vs-Grade 2 |
3.31920000040675E-07 |
| Normal-vs-Grade 3 |
2.38669999996777E-06 |
| Normal-vs-Grade 4 |
2.27189999999489E-05 |
| Grade 1-vs-Grade 2 |
2.775200E-01 |
| Grade 1-vs-Grade 3 |
2.997000E-01 |
| Grade 1-vs-Grade 4 |
9.317600E-01 |
| Grade 2-vs-Grade 3 |
9.387000E-01 |
| Grade 2-vs-Grade 4 |
1.094560E-01 |
| Grade 3-vs-Grade 4 |
1.070450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.66490000025932E-07 |
| Normal-vs-ccB subtype |
7.756000E-04 |
| ccA subtype-vs-ccB subtype |
5.429000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.83520000096982E-08 |
| Normal-vs-N1 |
4.339900E-02 |
| N0-vs-N1 |
7.437800E-01 |
|
|
